Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Marder

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Archives of Neurology|March 1, 1997
Mortality from Parkinson diseaseE D Louis, K Marder, L Cote, et al.
American Journal of Diseases of Children (1960)|November 1, 1988
Effect of calcitonin replacement therapy in idiopathic juvenile osteoporosisE C Jackson, C F Strife, R C Tsang, et al.
Clinical Neuropharmacology|February 1, 1993
Safety and efficacy of oral physostigmine in the treatment of Alzheimer diseaseM Sano, K Bell, K Marder, et al.
Archives of Neurology|November 1, 1991
Interrater reliability of extrapyramidal signs in a group assessed for dementiaM Richards, K Marder, K Bell, et al.
Archives of Neurology|March 1, 1992
An estimate of the incidence of depression in idiopathic Parkinson's diseaseG Dooneief, E Mirabello, K Bell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
Smoking and Parkinson's diseaseR Mayeux, M X Tang, K Marder, et al.
Pediatric Research|April 1, 1981
Hypocomplementemia in Reye syndrome: relationship to disease stage, circulating immune complexes, and C3b amplification loop protein synthesisH K Marder, C F Strife, J Forristal, et al.
Archives of Neurology|July 1, 1995
Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug usersN Sacktor, X Liu, M Popescu, et al.
Annals of Neurology|January 1, 1996
Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control studyG Logroscino, K Marder, L Cote, et al.
Neurology|September 12, 2001
Objective assessment of progression in Huntington's disease: a 3-year follow-up studyR Reilmann, F Kirsten, L Quinn, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Archives of Neurology|March 1, 1997
Mortality from Parkinson diseaseE D Louis, K Marder, L Cote, et al.
American Journal of Diseases of Children (1960)|November 1, 1988
Effect of calcitonin replacement therapy in idiopathic juvenile osteoporosisE C Jackson, C F Strife, R C Tsang, et al.
Clinical Neuropharmacology|February 1, 1993
Safety and efficacy of oral physostigmine in the treatment of Alzheimer diseaseM Sano, K Bell, K Marder, et al.
Archives of Neurology|November 1, 1991
Interrater reliability of extrapyramidal signs in a group assessed for dementiaM Richards, K Marder, K Bell, et al.
Archives of Neurology|March 1, 1992
An estimate of the incidence of depression in idiopathic Parkinson's diseaseG Dooneief, E Mirabello, K Bell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
Smoking and Parkinson's diseaseR Mayeux, M X Tang, K Marder, et al.
Pediatric Research|April 1, 1981
Hypocomplementemia in Reye syndrome: relationship to disease stage, circulating immune complexes, and C3b amplification loop protein synthesisH K Marder, C F Strife, J Forristal, et al.
Archives of Neurology|July 1, 1995
Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug usersN Sacktor, X Liu, M Popescu, et al.
Annals of Neurology|January 1, 1996
Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control studyG Logroscino, K Marder, L Cote, et al.
Neurology|September 12, 2001
Objective assessment of progression in Huntington's disease: a 3-year follow-up studyR Reilmann, F Kirsten, L Quinn, et al.
Pageof 17